tirzepatide diabetes trial once weekly for the treatment of obesity in people with type 2 (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 Tirzepatide as Compared with Semaglutide

Gastrointestinal adverse effectsincluding nausea (occurring in up to 43% of patients at higher doses), vomiting, diarrhea, and abdominal discomfortmay trigger or exacerbate anxiety symptoms in susceptible individuals

In this blog, we will explore what visceral fat is, its symptoms and causes, the dangers it poses, and different ways to get rid of visceral fat and improve overall well-being

In the Phase 2 trial protocol, participants began at a low starting dose commonly 2 mg once weekly before progressing through incremental increases over several months, with target maintenance doses ranging from 8 mg to 12 mg weekly depending on tolerability and clinical response

The hormone GLP-1, or glucagon-like peptide-1, helps the body regulate blood sugar levels

Therefore, although the body produces it naturally, athletes have a greater need for l-carnitine than others